Introduction to cost-effectiveness analysis for infectious diseases
24 April 2017. Related: Other news.
A two-day course on cost-effectiveness analyses is being organised by UCL.
Thursday 28th and Friday 29th September 2017
UCL Royal Free Campus,
Rowland Hill Street, London, NW3 2PF
The course is for people who wish to achieve a basic understanding of, and be able to interpret, cost effectiveness analyses in the context of infectious diseases, with particular focus on HIV. It is particularly designed for working in health care settings, academic environments, industry and governmental and non-governmental organisations.
No prior knowledge of cost effectiveness analysis is needed for this course.
The course includes:
- Principles of economic evaluation of health care programmes.
- Basic aspects of infectious disease modelling.
- The use and role of economic evaluations in helping to make decisions, with particular regard to infectious diseases.
- The interactive and informal course will be led by Dr Valentina Cambiano and Professor Andrew Phillips from UCL Institute for Global Health.
In addition, specific sessions will be led by Dr Loveleen Bansi (UCL), Professor John Cairns (LSHTM), Dr Tim Colbourn (UCL), Dr Alec Miners (LSHM), Dr Jasmina Panovska- Griffith (UCL), Dr Elena Pizzo (UCL), Paul Revill (University of York), Dr Alison Rodger (UCL) and Professor Mark Sculpher (University of York).
In order to maintain a low participant to tutor ratio, attendee numbers will be limited.
Price: NHS/Academic: £500 Pharmaceutical Industry: £1,000
Lunch and refreshments breaks will be included. Participants will be responsible for their own travel and accommodation costs.
For further information please contact:
Pat Withington
Tel: 020 7794 0500, ext. 34871; Email: p.withington@ucl.ac.uk